Annual Total Liabilities
$3.83 M
+$1.58 M+70.20%
December 31, 2023
Summary
- As of February 8, 2025, MBOT annual total liabilities is $3.83 million, with the most recent change of +$1.58 million (+70.20%) on December 31, 2023.
- During the last 3 years, MBOT annual total liabilities has risen by +$1.85 million (+94.11%).
- MBOT annual total liabilities is now -85.62% below its all-time high of $26.60 million, reached on December 31, 2013.
Performance
MBOT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.40 M
+$21.00 K+1.52%
September 30, 2024
Summary
- As of February 8, 2025, MBOT quarterly total liabilities is $1.40 million, with the most recent change of +$21.00 thousand (+1.52%) on September 30, 2024.
- Over the past year, MBOT quarterly total liabilities has dropped by -$2.43 million (-63.41%).
- MBOT quarterly total liabilities is now -95.47% below its all-time high of $30.90 million, reached on June 30, 2014.
Performance
MBOT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MBOT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.2% | -63.4% |
| 3 y3 years | +94.1% | -63.4% |
| 5 y5 years | -19.6% | -63.4% |
MBOT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.2% | -63.4% | +16.7% |
| 5 y | 5-year | -31.5% | +94.1% | -74.9% | +16.7% |
| alltime | all time | -85.6% | +545.2% | -95.5% | +136.1% |
Microbot Medical Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.40 M(+1.5%) |
| Jun 2024 | - | $1.38 M(+14.9%) |
| Mar 2024 | - | $1.20 M(-68.6%) |
| Dec 2023 | $3.83 M(+70.2%) | $3.83 M(+150.1%) |
| Sep 2023 | - | $1.53 M(+8.1%) |
| Jun 2023 | - | $1.42 M(+4.1%) |
| Mar 2023 | - | $1.36 M(-39.5%) |
| Dec 2022 | $2.25 M(-5.8%) | $2.25 M(+19.8%) |
| Sep 2022 | - | $1.88 M(-6.3%) |
| Jun 2022 | - | $2.00 M(-2.9%) |
| Mar 2022 | - | $2.06 M(-13.6%) |
| Dec 2021 | $2.39 M(+21.1%) | $2.39 M(+30.3%) |
| Sep 2021 | - | $1.83 M(+4.8%) |
| Jun 2021 | - | $1.75 M(-5.1%) |
| Mar 2021 | - | $1.84 M(-6.6%) |
| Dec 2020 | $1.97 M(-64.7%) | $1.97 M(+27.3%) |
| Sep 2020 | - | $1.55 M(+2.0%) |
| Jun 2020 | - | $1.52 M(-6.3%) |
| Mar 2020 | - | $1.62 M(-71.0%) |
| Dec 2019 | $5.59 M(+17.4%) | $5.59 M(+18.3%) |
| Sep 2019 | - | $4.72 M(+2.7%) |
| Jun 2019 | - | $4.59 M(-1.8%) |
| Mar 2019 | - | $4.68 M(-1.7%) |
| Dec 2018 | $4.76 M(+350.8%) | $4.76 M(+348.2%) |
| Sep 2018 | - | $1.06 M(-2.9%) |
| Jun 2018 | - | $1.09 M(+11.3%) |
| Mar 2018 | - | $983.00 K(-6.9%) |
| Dec 2017 | $1.06 M(-36.8%) | $1.06 M(+1.0%) |
| Sep 2017 | - | $1.05 M(-19.9%) |
| Jun 2017 | - | $1.31 M(-27.0%) |
| Mar 2017 | - | $1.79 M(+6.9%) |
| Dec 2016 | $1.67 M(+182.0%) | $1.67 M(-60.8%) |
| Sep 2016 | - | $4.27 M(-62.0%) |
| Jun 2016 | - | $11.21 M(-53.8%) |
| Mar 2016 | - | $24.27 M(+3992.9%) |
| Dec 2015 | $593.00 K(-97.8%) | $593.00 K(-97.2%) |
| Sep 2015 | - | $21.27 M(-2.1%) |
| Jun 2015 | - | $21.72 M(-7.9%) |
| Mar 2015 | - | $23.60 M(-11.1%) |
| Dec 2014 | $26.56 M(-0.2%) | $26.56 M(-1.7%) |
| Sep 2014 | - | $27.02 M(-12.6%) |
| Jun 2014 | - | $30.90 M(+5.9%) |
| Mar 2014 | - | $29.17 M(+9.7%) |
| Dec 2013 | $26.60 M(+64.4%) | $26.60 M(-7.5%) |
| Sep 2013 | - | $28.76 M(+13.7%) |
| Jun 2013 | - | $25.29 M(+73.8%) |
| Mar 2013 | - | $14.56 M(-10.1%) |
| Dec 2012 | $16.19 M(+11.8%) | $16.19 M(-20.8%) |
| Sep 2012 | - | $20.43 M(+76.3%) |
| Jun 2012 | - | $11.59 M(-35.4%) |
| Mar 2012 | - | $17.94 M(+23.9%) |
| Dec 2011 | $14.48 M(-4.2%) | $14.48 M(+70.7%) |
| Sep 2011 | - | $8.48 M(-10.3%) |
| Jun 2011 | - | $9.46 M(-22.5%) |
| Mar 2011 | - | $12.20 M(-19.3%) |
| Dec 2010 | $15.12 M(-26.9%) | $15.12 M(+19.6%) |
| Sep 2010 | - | $12.64 M(-12.4%) |
| Jun 2010 | - | $14.43 M(-16.5%) |
| Mar 2010 | - | $17.27 M(-16.5%) |
| Dec 2009 | $20.70 M(+6.6%) | $20.70 M(+5.0%) |
| Sep 2009 | - | $19.70 M(-12.1%) |
| Jun 2009 | - | $22.42 M(+2.7%) |
| Mar 2009 | - | $21.83 M(+12.4%) |
| Dec 2008 | $19.42 M | $19.42 M(+82.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $10.62 M(-4.2%) |
| Jun 2008 | - | $11.09 M(+2.9%) |
| Mar 2008 | - | $10.77 M(-17.6%) |
| Dec 2007 | $13.07 M(+4.7%) | $13.07 M(+5.1%) |
| Sep 2007 | - | $12.44 M(+7.3%) |
| Jun 2007 | - | $11.59 M(-2.6%) |
| Mar 2007 | - | $11.89 M(-4.7%) |
| Dec 2006 | $12.48 M(+0.1%) | $12.48 M(+8.1%) |
| Sep 2006 | - | $11.54 M(-5.7%) |
| Jun 2006 | - | $12.24 M(+2.6%) |
| Mar 2006 | - | $11.93 M(-4.3%) |
| Dec 2005 | $12.46 M(+16.7%) | $12.46 M(+12.6%) |
| Sep 2005 | - | $11.07 M(+1.3%) |
| Jun 2005 | - | $10.93 M(+8.3%) |
| Mar 2005 | - | $10.09 M(-5.5%) |
| Dec 2004 | $10.68 M(+21.0%) | $10.68 M(+4.8%) |
| Sep 2004 | - | $10.19 M(+20.9%) |
| Jun 2004 | - | $8.43 M(-0.3%) |
| Mar 2004 | - | $8.46 M(-4.2%) |
| Dec 2003 | $8.82 M(+17.0%) | $8.82 M(+31.8%) |
| Sep 2003 | - | $6.69 M(-0.9%) |
| Jun 2003 | - | $6.75 M(-14.4%) |
| Mar 2003 | - | $7.88 M(+4.5%) |
| Dec 2002 | $7.54 M(-0.7%) | $7.54 M(-15.6%) |
| Sep 2002 | - | $8.93 M(+8.8%) |
| Jun 2002 | - | $8.21 M(+1.5%) |
| Mar 2002 | - | $8.09 M(+6.6%) |
| Dec 2001 | $7.60 M(+11.5%) | $7.60 M(+40.3%) |
| Sep 2001 | - | $5.41 M(-12.4%) |
| Jun 2001 | - | $6.17 M(+2.1%) |
| Mar 2001 | - | $6.04 M(-11.3%) |
| Dec 2000 | $6.81 M(-44.5%) | $6.81 M(+51.2%) |
| Sep 2000 | - | $4.51 M(-5.8%) |
| Jun 2000 | - | $4.78 M(-3.9%) |
| Mar 2000 | - | $4.98 M(-59.4%) |
| Dec 1999 | $12.27 M(-18.2%) | $12.27 M(+11.6%) |
| Sep 1999 | - | $11.00 M(-6.8%) |
| Jun 1999 | - | $11.80 M(-4.8%) |
| Mar 1999 | - | $12.40 M(-17.3%) |
| Dec 1998 | $15.00 M(-2.6%) | $15.00 M(+10.3%) |
| Sep 1998 | - | $13.60 M(-20.5%) |
| Jun 1998 | - | $17.10 M(+113.8%) |
| Mar 1998 | - | $8.00 M(-48.1%) |
| Dec 1997 | $15.40 M(-35.0%) | $15.40 M(-30.3%) |
| Sep 1997 | - | $22.10 M(+12.2%) |
| Jun 1997 | - | $19.70 M(-15.8%) |
| Mar 1997 | - | $23.40 M(-1.3%) |
| Dec 1996 | $23.70 M(+107.9%) | $23.70 M(+78.2%) |
| Sep 1996 | - | $13.30 M(+17.7%) |
| Jun 1996 | - | $11.30 M(+18.9%) |
| Mar 1996 | - | $9.50 M(-16.7%) |
| Dec 1995 | $11.40 M(+18.8%) | $11.40 M(+1.8%) |
| Sep 1995 | - | $11.20 M(-3.4%) |
| Jun 1995 | - | $11.60 M(+4.5%) |
| Mar 1995 | - | $11.10 M(+15.6%) |
| Dec 1994 | $9.60 M(+47.7%) | $9.60 M(+41.2%) |
| Sep 1994 | - | $6.80 M(+9.7%) |
| Jun 1994 | - | $6.20 M(+1.6%) |
| Mar 1994 | - | $6.10 M(-6.2%) |
| Dec 1993 | $6.50 M(+8.3%) | $6.50 M(+14.0%) |
| Jun 1993 | - | $5.70 M(-6.6%) |
| Mar 1993 | - | $6.10 M(+1.7%) |
| Dec 1992 | $6.00 M(+150.0%) | $6.00 M(+150.0%) |
| Dec 1991 | $2.40 M | $2.40 M |
FAQ
- What is Microbot Medical annual total liabilities?
- What is the all time high annual total liabilities for Microbot Medical?
- What is Microbot Medical annual total liabilities year-on-year change?
- What is Microbot Medical quarterly total liabilities?
- What is the all time high quarterly total liabilities for Microbot Medical?
- What is Microbot Medical quarterly total liabilities year-on-year change?
What is Microbot Medical annual total liabilities?
The current annual total liabilities of MBOT is $3.83 M
What is the all time high annual total liabilities for Microbot Medical?
Microbot Medical all-time high annual total liabilities is $26.60 M
What is Microbot Medical annual total liabilities year-on-year change?
Over the past year, MBOT annual total liabilities has changed by +$1.58 M (+70.20%)
What is Microbot Medical quarterly total liabilities?
The current quarterly total liabilities of MBOT is $1.40 M
What is the all time high quarterly total liabilities for Microbot Medical?
Microbot Medical all-time high quarterly total liabilities is $30.90 M
What is Microbot Medical quarterly total liabilities year-on-year change?
Over the past year, MBOT quarterly total liabilities has changed by -$2.43 M (-63.41%)